Toboroz
BIO|STREAM.CSP Study
NCT07393009· Biotronik SE & Co. KG· Forrás
Contact: Johannes Pfaffenberger
Toboroz
Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
NCT07298473· Medtronic Cardiac Ablation Solutions· Forrás
Contact: Tobias Reichlin
Toboroz
A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
NCT07493265· 2. fázis· Eisai Inc.· Forrás
Fut, nem toboroz
WATCHMAN FLX Pro European Registry
NCT07262255· Boston Scientific Corporation· Forrás
Toboroz
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
NCT07196722· 2/3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC)
NCT07082725· 3. fázis· Azafaros B.V.· Forrás
Contact: Sandrina Schneider
Toboroz
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis
NCT07054515· 3. fázis· Azafaros B.V.· Forrás
Contact: Sandrina Schneider
Toboroz
Effect of Cognitively Challenging Physical Activity on Executive Functions in Pediatric Cancer Patients
NCT06839794· University of Bern· Forrás
Contact: Eva Brack, PD Dr. Dr.
Fut, nem toboroz
REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve Failure
NCT06557798· The Leeds Teaching Hospitals NHS Trust· Forrás
Toboroz
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
NCT06635148· 2/3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma
NCT06413498· 3. fázis· Kite, A Gilead Company· Forrás
Fut, nem toboroz
Affera Global Registry
NCT06026345· Medtronic Cardiac Ablation Solutions· Forrás
Toboroz
Post-Market Registry for the Evaluation of RefluxStop in GERD Treatment
NCT05870163· Implantica CE Reflux Ltd.· Forrás
Contact: Yves Borbély, Dr. med.
Fut, nem toboroz
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
NCT05702034· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
NCT05701917· Inari Medical· Forrás
Contact: Marc Schindewolf, Dr. med.
Toboroz
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
NCT06146738· Jasper Gerritsen· Forrás
Contact: Philippe Schucht, MD PhD
Toboroz
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
NCT06146725· Jasper Gerritsen· Forrás
Contact: Philippe Schucht, MD PhD
Toboroz
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
NCT06283927· Jasper Gerritsen· Forrás
Contact: Philippe Schucht, MD PhD
Toboroz
The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
NCT06273176· Erasmus Medical Center· Forrás
Contact: Philippe Schucht, MD PhD
Fut, nem toboroz
Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS
NCT05688280· 1/2. fázis· Immunophotonics, Inc.· Forrás
Toboroz
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
NCT05552222· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
NCT05242484· 2. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
NCT05242471· 2. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
SIGNATURE Study : DCB (Legflow) vs POBA in Fempop Arteries
NCT04971772· Cardionovum GmbH· Forrás
Fut, nem toboroz
Evolut™ EXPAND TAVR II Pivotal Trial
NCT05149755· Medtronic Cardiovascular· Forrás
Toboroz
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
NCT06118723· Jasper Gerritsen· Forrás
Contact: Philippe Schucht, MD PhD
Fut, nem toboroz
A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy
NCT04923893· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
NCT04798261· Penumbra Inc.· Forrás
Contact: Joanne Krasnoff
Fut, nem toboroz
SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial
NCT04722250· Medtronic Cardiovascular· Forrás
Fut, nem toboroz
Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia
NCT04579367· Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company· Forrás
Fut, nem toboroz
Cusatuzumab in Combination With Background Therapy for the Treatment of Participants With Acute Myeloid Leukemia
NCT04150887· 1. fázis· OncoVerity, Inc.· Forrás
Fut, nem toboroz
A Study of Cusatuzumab Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy
NCT04023526· 2. fázis· OncoVerity, Inc.· Forrás
Fut, nem toboroz
Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients
NCT03049189· 3. fázis· ITM Solucin GmbH· Forrás
Fut, nem toboroz
Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
NCT02598661· 2/3. fázis· Geron Corporation· Forrás
Fut, nem toboroz
PERIGON Pivotal Trial
NCT02088554· Medtronic Cardiac Surgery· Forrás
Toboroz
Patient Selection and Long-Term Outcomes of Pace & Ablate Strategy in Atrial Fibrillation
NCT07852221· Insel Gruppe AG, University Hospital Bern· Forrás
Contact: Nikola A Kozhuharov, PD Dr. med.